|Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 581 active entries
Genavenir 8 - 5, rue Henri Desbručres
Phone: +33 1 60 91 21 21
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Biomehodes is a technological leader in directed evolution and protein engineering.
We have developed Massive Mutagenesis®, the only high throughput combinatorial site-directed mutagenesis technology, with a main application to direct molecular evolution of industrial enzymes and therapeutic proteins.
This technology allows the generation of complex protein variants at a high throughput and has been widely validated through over 30 research projects.
Molecular Evolution; Mutagenesis; High-throughput Screening; Bioinformatics; Industrial Enzymes
Therapeutic Proteins; Recombinant Antibodies
Last update of this entry: November 15, 2005